New Edge Advisors, LLC Johnson & Johnson Transaction History

New Edge Advisors, LLC

$13.5 Billion
Q2 2024

A detailed history of New Edge Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, New Edge Advisors, LLC holds 268,520 shares of JNJ stock, worth $44.6 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

268,520

Previous 240,816 11.5%

Holding current value

$44.6 Million

Previous $38.1 Million 3.02%

% of portfolio

0.29%

Previous 0.34%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$144.38 - $157.78 $4 Million - $4.37 Million	27,704 Added 11.5%	268,520 $39.2 Million
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $895,153 - $938,521	-5,767 Reduced 2.34%	240,816 $38.1 Million
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $257,712 - $281,217	1,770 Added 0.72%	246,583 $38.6 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $488,743 - $547,518	3,138 Added 1.3%	244,813 $38.1 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $579,738 - $623,909	3,756 Added 1.58%	241,675 $40 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $1.1 Million - $1.31 Million	7,286 Added 3.16%	237,919 $36.9 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $5.59 Million - $6.27 Million	34,869 Added 17.81%	230,633 $40.7 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $557,233 - $620,062	-3,454 Reduced 1.73%	195,764 $32 Million
Q2 2022 Aug 09, 2022	BUY	$168.19 - $186.01 $8.26 Million - $9.13 Million	49,094 Added 32.7%	199,218 $35.4 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $198,465 - $225,385	1,255 Added 0.84%	150,124 $26.6 Million
Q4 2021 Feb 17, 2022	BUY	$155.93 - $173.01 $10.9 Million - $12 Million	69,590 Added 87.78%	148,869 $25.5 Million
Q3 2021 Oct 29, 2021	SELL	$161.5 - $179.47 $766,479 - $851,764	-4,746 Reduced 5.65%	79,279 $12.8 Million
Q2 2021 Jul 22, 2021	SELL	$159.48 - $171.07 $17.7 Million - $19 Million	-110,955 Reduced 56.91%	84,025 $13.8 Million
Q1 2021 Apr 26, 2021	BUY	$153.07 - $170.48 $18.8 Million - $20.9 Million	122,497 Added 169.0%	194,980 $32 Million
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $6.06 Million - $6.95 Million	-44,168 Reduced 37.86%	72,483 $11.4 Million
Q3 2020 Nov 03, 2020	BUY	$140.38 - $153.83 $767,457 - $840,988	5,467 Added 4.92%	116,651 $17.4 Million
Q2 2020 Jul 29, 2020	BUY	$128.81 - $155.51 $3.56 Million - $4.3 Million	27,632 Added 33.07%	111,184 $15.6 Million
Q1 2020 May 04, 2020	BUY	$111.14 - $153.99 $1.26 Million - $1.74 Million	11,293 Added 15.63%	83,552 $11 Million
Q4 2019 Jan 31, 2020	SELL	$127.5 - $146.44 $91,290 - $104,851	-716 Reduced 0.98%	72,259 $10.5 Million
Q3 2019 Nov 06, 2019	BUY	$126.95 - $142.14 $3.25 Million - $3.64 Million	25,579 Added 53.97%	72,975 $9.4 Million
Q2 2019 Aug 05, 2019	BUY	$131.15 - $144.24 $103,215 - $113,516	787 Added 1.69%	47,396 $6.6 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $5.86 Million - $6.52 Million	46,609 New	46,609 $6.52 Million
Q1 2019 May 09, 2019	SELL	$125.72 - $139.79 $5.64 Million - $6.28 Million	-44,900 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$122.84 - $147.84 $541,970 - $652,270	-4,412 Reduced 8.95%	44,900 $5.79 Million
Q3 2018 Oct 29, 2018	BUY	$121.58 - $142.88 $38,297 - $45,007	315 Added 0.64%	49,312 $6.81 Million
Q2 2018 Jul 19, 2018	BUY	$119.4 - $131.76 $801,054 - $883,977	6,709 Added 15.87%	48,997 $5.96 Million
Q1 2018 May 11, 2018	BUY	$125.1 - $148.14 $357,285 - $423,087	2,856 Added 7.24%	42,288 $5.27 Million
Q4 2017 Feb 08, 2018	SELL	$131.22 - $143.62 $45,008 - $49,261	-343 Reduced 0.86%	39,432 $5.6 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $514,643 - $538,135	3,975 Added 11.1%	39,775 $5.31 Million
Q2 2017 Aug 16, 2017	BUY	N/A	35,800	35,800 $0

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Johnson & Johnson Transaction History